The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort
Kjellin, Midori, Wesslén, Terése, Löfblad, Erik, Lennerstrand, Johan, Lannergård, Anders
- ISSN / E-ISSN
- — / —
- DOI
- 10.1080/03009734.2018.1441928 ↗
- Volume · Issue · Pages
- 123 · 1 · —
- Publisher
- Upsala Medical Society
- Article URL
- https://ujms.net/index.php/ujms/article/view/5824 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
14 Mar 2018
Publisher publication date · source: Journal websites (OAI-PMH feeds of Open Journal Systems)
| Type | Date | Source |
|---|---|---|
| Publisher publication date | 14 Mar 2018 | Journal websites (OAI-PMH feeds of Open Journal Systems) |
Keywords (as given): Boceprevir; hepatitis C; protease inhibitor; RAS; resistance association substitution; telaprevir
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Upsala Journal of Medical Sciences
- Publication date used
- 14 Mar 2018 (Publisher publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.
